![](https://medcitynews.com/wp-content/uploads/sites/7/2015/12/3080247531_bf04a5cbe5_z-e1450188380962.jpg)
Former Affymetrix execs make offer for company that competes with Thermo Fisher’s
The new company, called Origin Technologies, are making this play about a week before Affymetrix shareholders plan to vote on the Thermo Fisher deal. The new bid will offer shareholders $16.10 per share in cash, up from Thermo Fisher's offer of $14 per share, as the New York Times points out.